(Q44162459)

30 November 2017

title

Contribution of obesity to hepatitis C-related fibrosis progression (English)

1 reference

30 November 2017

0 references

Vicente Ortiz

1 reference

30 November 2017

Marina Berenguer

1 reference

30 November 2017

José M Rayón

1 reference

30 November 2017

Domingo Carrasco

1 reference

30 November 2017

Joaquin Berenguer

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

The American Journal of Gastroenterology

30 November 2017

published in

1 reference

30 November 2017

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

2408-2414

1 reference

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

Impact of alcohol on the histological and clinical progression of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

The epidemiology of hepatitis C in a UK health regional population of 5.12 million

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05995.X

10.1111/J.1572-0241.2002.05995.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference